China Cord Blood Corp (CO) Shares Bought by California Public Employees Retirement System

California Public Employees Retirement System lifted its position in shares of China Cord Blood Corp (NYSE:CO) by 32.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 182,609 shares of the medical research company’s stock after purchasing an additional 44,909 shares during the period. California Public Employees Retirement System owned 0.15% of China Cord Blood worth $2,031,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the company. State Street Corp increased its stake in shares of China Cord Blood by 1.7% during the 2nd quarter. State Street Corp now owns 30,056 shares of the medical research company’s stock worth $284,000 after purchasing an additional 506 shares during the last quarter. MML Investors Services LLC acquired a new position in shares of China Cord Blood during the 2nd quarter worth about $104,000. Jane Street Group LLC acquired a new position in shares of China Cord Blood during the 3rd quarter worth about $137,000. PEAK6 Investments L.P. increased its stake in shares of China Cord Blood by 8.4% during the 3rd quarter. PEAK6 Investments L.P. now owns 175,657 shares of the medical research company’s stock worth $1,953,000 after purchasing an additional 13,657 shares during the last quarter. Finally, Parametric Portfolio Associates LLC increased its stake in shares of China Cord Blood by 82.5% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 34,542 shares of the medical research company’s stock worth $327,000 after purchasing an additional 15,620 shares during the last quarter. Institutional investors own 9.05% of the company’s stock.

Shares of China Cord Blood Corp (NYSE CO) traded down $0.04 during mid-day trading on Friday, hitting $10.22. 166,006 shares of the company traded hands, compared to its average volume of 206,978. The company has a market cap of $1,232.57, a P/E ratio of 29.20 and a beta of 0.91. China Cord Blood Corp has a 1-year low of $5.06 and a 1-year high of $14.95.

China Cord Blood (NYSE:CO) last announced its earnings results on Monday, November 20th. The medical research company reported $0.09 EPS for the quarter. The business had revenue of $35.26 million during the quarter. China Cord Blood had a net margin of 26.79% and a return on equity of 9.68%.

WARNING: This report was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this report on another site, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this report can be viewed at https://stocknewstimes.com/2018/02/11/california-public-employees-retirement-system-buys-44909-shares-of-china-cord-blood-corp-co.html.

China Cord Blood Company Profile

China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee.

Institutional Ownership by Quarter for China Cord Blood (NYSE:CO)

Receive News & Ratings for China Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply